Grisenti; Paride

Patent Applications and Registrations

Patent applications and USPTO patent grants for Grisenti; Paride.The latest application filed is for "polymorphic mixture of rifaximin and its use for the preparation of solid formulations".

Company Profile

6.14.13

Grisenti; Paride - Milano IT
Grisenti; Paride - Milan IT
Grisenti; Paride - Quinto de'Stampi IT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Polymorphic Mixture Of Rifaximin And Its Use For The Preparation Of Solid Formulations App 20220048926 - Grisenti; Paride ; et al.	2022-02-17
Polymorphic Mixture Of Rifaximin And Its Use For The Preparation Of Solid Formulations App 20220041622 - Grisenti; Paride ; et al.	2022-02-10
Polymorphic Mixture Of Rifaximin And Its Use For The Preparation Of Solid Formulations App 20210147444 - Grisenti; Paride ; et al.	2021-05-20
Polymorphic mixture of rifaximin and its use for the preparation of solid formulations Grant 10,961,257 - Grisenti , et al. March 30, 2	2021-03-30
Polymorphic mixture of Rifaximin and its use for the preparation of solid formulations Grant 10,745,415 - Grisenti , et al. A	2020-08-18
Polymorphic mixture of Rifaximin and its use for the preparation of solid formulations Grant 10,556,915 - Grisenti , et al. Feb	2020-02-11
Polymorphic Mixture Of Rifaximin And Its Use For The Preparation Of Solid Formulations App 20200002357 - Grisenti; Paride ; et al.	2020-01-02
Polymorphic Mixture Of Rifaximin And Its Use For The Preparation Of Solid Formulations App 20200002356 - Grisenti; Paride ; et al.	2020-01-02
Stable solid forms of regadenoson Grant 10,144,756 - Grisenti , et al. De	2018-12-04
Crystalline form of tiotropium bromide with lactose Grant 9,765,082 - Grisenti , et al. September 19, 2	2017-09-19
Biocatalyzed synthesis of the optically pure (R) and (S) 3-methyl-1,2,3,4-tetrahydroquinoline and their use as chiral synthons for the preparation of the antithrombic (21R)- and (21S)-argatroban Grant 9,630,923 - Grisenti April 25, 2	2017-04-25
Crystalline Form Of Tiotropium Bromide With Lactose App 20170044176 - Grisenti; Paride ; et al.	2017-02-16
Polymorphic Mixture Of Rifaximin And Its Use For The Preparation Of Solid Formulations App 20170015682 - Grisenti; Paride ; et al.	2017-01-19
Biocatalyzed synthesis of the optically pure (R) and (S) 3-methyl-1,2,3,4-tetrahydroquinoline and their use as chiral synthons for the preparation of the antithrombic (21R)- and (21S)-argatroban App 20160122303 - Grisenti; Paride	2016-05-05
Stable Solid Forms Of Regadenoson App 20160024137 - Grisenti; Paride ; et al.	2016-01-28
Water-soluble solid pharmaceutical inclusion complexes and their aqueous solutions for oral, ophthalmic, topical or parenteral use containing a macrolide and certain cyclodextrins Grant 9,169,269 - Mangia , et al. October 27, 2	2015-10-27
Chemo-enzymatic approach to the synthesis of pimecrolimus Grant 8,778,636 - Grisenti , et al. July 15, 2	2014-07-15
Chemo-enzymatic Approach To The Synthesis Of Pimecrolimus App 20120064575 - Grisenti; Paride ; et al.	2012-03-15
Water-soluble Solid Pharmaceutical Inclusion Complexes And Their Aqueous Solutions For Oral, Ophthalmic, Topical Or Parenteral Use Containing A Macrolide And Certain Cyclodextrins App 20120053198 - Mangia; Alberto ; et al.	2012-03-01
Method for the preparation of mycophenolate mofetil by enzyme tranesterification Grant 7,727,751 - Grisenti , et al. June 1, 2	2010-06-01
Process and new intermediates for the preparation of steroids with a progestogen activity Grant 7,667,056 - Grisenti , et al. February 23, 2	2010-02-23
Method For The Preparation Of Mycophenolate Mofetil By Enzymatic Tranesterification App 20080085542 - Grisenti; Paride ; et al.	2008-04-10
Process and new intermediates for the preparation of steroids with a progestogen activity App 20050234251 - Grisenti, Paride ; et al.	2005-10-20
Process for the preparation of alkyl mercapto methyl ergoline derivatives Grant 6,395,901 - Mangia , et al. May 28, 2	2002-05-28
Diastereomerically pure 3-oxo and 3-thioxo-4-aza-androstan derivatives and the use thereof as antiandrogens Grant 6,147,213 - Poli , et al. November 14, 2	2000-11-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.